Healthy Clinical Trial
Official title:
The Effects of Respiratory Motion on CT Based Attenuation Correction of Positron Emission Tomography Data: Liver and Heart Studies
This study will determine how breathing motions may affect positron emission tomography
(PET) scans. It has been discovered that the quality of PET scans varies according to which
part of the breathing cycle patients hold their breath.
NIH Clinical Center patients 12 years of age and older who are scheduled to have PET and
computed tomography (CT) scans as part of their standard medical care may be eligible for
this study.
Participants have their scheduled PET or CT scan as they normally would and are asked to
hold their breath after breathing out, as is usual. In addition, for this study, patients
are also asked hold their breath after breathing in and again at a point between breathing
in and out. Each breath-hold is for around 15 seconds. The scans for each of the three
different breath-holds are examined for differences.
Some patients may also be asked to breathe through a tube called a pneumotachometer, or
spirometer, to determine their normal breathing pattern. This involves breathing through a
mouthpiece similar to a snorkel mouthpiece and takes about 2 minutes.
Current clinical FDG imaging with the NIH's PET/CT machine (and in fact with most commercial
PET/CT machines) requires a CT scan be acquired prior to the PET scan. This CT scan is used
for attenuation correction of the PET data and to permit fusion of anatomical and metabolic
image data.
One difficulty with use of the CT scan for attenuation correction ('CTAC') is that the CT
scan is rapid compared to the breathing cycle. Each CT slice captures the lungs at one
(usually arbitrary) phase of the respiratory cycle. The PET data on the other hand take many
minutes to acquire, and so average the motion effects of the entire respiratory cycle
together. This 'freezing' of the respiratory cycle by the CT, and blurring of the
respiratory cycle during PET produces a mis-match between the PET and CT data. This
mis-match can produce improper attenuation correction during PET reconstruction, especially
at soft tissue/lung interfaces. The existence of this phenomenon has been reported in the
literature [1-7], especially at the dome of the liver, but it has not been thoroughly
quantified. Little or no data is available to indicate the quantitative errors the effect
produces in cardiac imaging[8]. This despite the fact that the myocardium is only about 10mm
thick, and it has been reported that the heart moves on average 9mm (and as much as 14mm)
during a single average respiratory cycle[9].
The purpose of this protocol is to determine the degree to which respiratory motion may
influence quantitative PET imaging, especially at the lung/liver interface and free wall of
myocardium. By characterizing the magnitude of the effect, we hope to gain knowledge about
when correction for the effect is and is not necessary. It is hoped that the information
gained will also allow us to suggest potential methods to perform such corrections.
To gain the above information we will modify the CT acquisition protocol for subjects
already scheduled to undergo a whole body FDG PET/CT scan. In summary, rather than acquiring
the usual single full radiation exposure CT (taking approx 20-30 seconds), we will acquire 3
CT scans (each taking approximately 20-30 seconds), each at 1/3 the usual radiation
exposure. Each CT will be acquired at a different phase of the respiratory cycle (as opposed
to current acquisition, which is only at end-expiration). The subsequent PET data will be
acquired as usual, but will be processed and analyzed separately with each of the CT scans
and also with a summed CT scan.
Note that subjects agreeing to participate in this protocol will receive no additional
radiation exposure. Participation in the protocol will extend the current overall scan time
(typically greater than 45 minutes) a very small amount (about 40-60 additional seconds for
imaging, and about 60 additional seconds for patient set up, etc).
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |